Literature DB >> 10783798

Approximate Bayesian evaluation of multiple treatment effects.

P F Thall1, R M Simon, Y Shen.   

Abstract

We propose an approximate Bayesian method for comparing an experimental treatment to a control based on a randomized clinical trial with multivariate patient outcomes. Overall treatment effect is characterized by a vector of parameters corresponding to effects on the individual patient outcomes. We partition the parameter space into four sets where, respectively, the experimental treatment is superior to the control, the control is superior to the experimental, the two treatments are equivalent, and the treatment effects are discordant. We compute posterior probabilities of the parameter sets by treating an estimator of the parameter vector like a random variable in the Bayesian paradigm. The approximation may be used in any setting where a consistent, asymptotically normal estimator of the parameter vector is available. The method is illustrated by application to a breast cancer data set consisting of multiple time-to-event outcomes with covariates and to count data arising from a cross-classification of response, infection, and treatment in an acute leukemia trial.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783798     DOI: 10.1111/j.0006-341x.2000.00213.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  3 in total

1.  Some Geometric Methods for Constructing Decision Criteria Based On Two-Dimensional Parameters.

Authors:  Peter F Thall
Journal:  J Stat Plan Inference       Date:  2008       Impact factor: 1.111

2.  Bayesian design using adult data to augment pediatric trials.

Authors:  David A Schoenfeld; Dianne M Finkelstein
Journal:  Clin Trials       Date:  2009-08       Impact factor: 2.486

3.  The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials.

Authors:  Janus Christian Jakobsen; Christian Gluud; Per Winkel; Theis Lange; Jørn Wetterslev
Journal:  BMC Med Res Methodol       Date:  2014-03-04       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.